RATIONALE: Aging may affect a person's vision. Vitamin E and/or selenium may help prevent cataracts or age-related macular degeneration in men receiving these drugs as part of a clinical trial for the prevention of prostate cancer. PURPOSE: This clinical trial is studying vitamin E and/or selenium to see how well they work in preventing cataract and age-related macular degeneration in men enrolled on SELECT (SWOG-S0000).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants With Visually Significant Age-related Macular Degeneration (AMD)
Timeframe: Every 6 months, up to 7 years
Number of Participants With Cataract and Best Corrected Visual-acuity of 20/30
Timeframe: Every 6 months, up to 7 years